Keisuke Steven Iwamoto

Keisuke Steven Iwamoto serves as an Adjunct Professor in the Department of Radiation Oncology within the David Geffen School of Medicine at the University of California Los Angeles (UCLA). His academic profile demonstrates a strong commitment to advancing radiation oncology through innovative research spanning radiation biology, cancer therapy, and radioprotection.

Dr. Iwamoto's research interests focus on the intersection of radiation therapy and molecular biology, with particular emphasis on radiation response mechanisms, immunotherapy combinations, and radiation protection strategies. His work spans from fundamental radiation biology to clinical applications, with significant contributions in lung cancer treatment, radiation-induced side effects, and novel therapeutic approaches. He has published extensively on topics including radiation-induced biomarkers, radioprotective compounds, and innovative imaging techniques for radiation therapy planning.

Analysis of his recent publications reveals a strong trend toward translational research that bridges basic science discoveries with clinical applications. His work demonstrates increasing focus on combining radiation therapy with immunotherapeutic approaches, developing radioprotective strategies, and applying artificial intelligence to improve radiation therapy planning and delivery. The research spans multiple disciplines including radiation biology, oncology, immunology, and medical physics, reflecting a highly interdisciplinary approach to advancing cancer treatment.

Dr. Iwamoto has secured significant research funding, including as Principal Investigator on the NIH R01AI128739 grant titled 'Exploiting multidrug resistance mechanisms to counter radiation toxicity' (2017-2022). His research has garnered attention across multiple platforms, with his publications being cited in news outlets, referenced on social media, and attracting numerous readers on academic platforms like Mendeley.

His work spans multiple collaborative environments, connecting with researchers across various specialties including radiation oncology, immunology, molecular biology, and medical physics. This interdisciplinary approach has enabled him to explore innovative solutions to challenges in radiation therapy, from developing radioprotective compounds to optimizing radiation delivery techniques and understanding the molecular basis of radiation response.